CTLA4 and melanoma: Recently, Riaz et al have found two neoantigens, SERPIN3 and SERPINB4, the human ovalbumin antigen, which are associated with autoimmunity, are also correlated with improved survival after anti-CTLA-4 immunotherapy in patients with melanoma [143].